[1]
“Neoadjuvant and adjuvant immunotherapy for non-small cell lung cancer (literature review)”, Вопр. онкол., vol. 68, no. 2, pp. 159–168, May 2022, doi: 10.37469/0507-3758-2022-68-2-159-168.